The Market Reports

Index

1 Antidepressant Medication Market Overview
1.1 Product Overview and Scope of Antidepressant Medication
1.2 Antidepressant Medication Segment by Type
1.2.1 Global Antidepressant Medication Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Monoamine Oxidase
1.2.3 Tricyclic
1.2.4 New Drugs
1.3 Antidepressant Medication Segment by Application
1.3.1 Global Antidepressant Medication Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Institute of Medicine
1.3.4 Clinic
1.3.5 Others
1.4 Global Antidepressant Medication Market Size Estimates and Forecasts
1.4.1 Global Antidepressant Medication Revenue 2017-2028
1.4.2 Global Antidepressant Medication Sales 2017-2028
1.4.3 Antidepressant Medication Market Size by Region: 2017 Versus 2021 Versus 2028
2 Antidepressant Medication Market Competition by Manufacturers
2.1 Global Antidepressant Medication Sales Market Share by Manufacturers (2017-2022)
2.2 Global Antidepressant Medication Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Antidepressant Medication Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Antidepressant Medication Manufacturing Sites, Area Served, Product Type
2.5 Antidepressant Medication Market Competitive Situation and Trends
2.5.1 Antidepressant Medication Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antidepressant Medication Players Market Share by Revenue
2.5.3 Global Antidepressant Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antidepressant Medication Retrospective Market Scenario by Region
3.1 Global Antidepressant Medication Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Antidepressant Medication Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Antidepressant Medication Market Facts & Figures by Country
3.3.1 North America Antidepressant Medication Sales by Country
3.3.2 North America Antidepressant Medication Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Antidepressant Medication Market Facts & Figures by Country
3.4.1 Europe Antidepressant Medication Sales by Country
3.4.2 Europe Antidepressant Medication Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antidepressant Medication Market Facts & Figures by Region
3.5.1 Asia Pacific Antidepressant Medication Sales by Region
3.5.2 Asia Pacific Antidepressant Medication Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Antidepressant Medication Market Facts & Figures by Country
3.6.1 Latin America Antidepressant Medication Sales by Country
3.6.2 Latin America Antidepressant Medication Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Antidepressant Medication Market Facts & Figures by Country
3.7.1 Middle East and Africa Antidepressant Medication Sales by Country
3.7.2 Middle East and Africa Antidepressant Medication Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Antidepressant Medication Historic Market Analysis by Type
4.1 Global Antidepressant Medication Sales Market Share by Type (2017-2022)
4.2 Global Antidepressant Medication Revenue Market Share by Type (2017-2022)
4.3 Global Antidepressant Medication Price by Type (2017-2022)
5 Global Antidepressant Medication Historic Market Analysis by Application
5.1 Global Antidepressant Medication Sales Market Share by Application (2017-2022)
5.2 Global Antidepressant Medication Revenue Market Share by Application (2017-2022)
5.3 Global Antidepressant Medication Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Alkermes Plc
6.1.1 Alkermes Plc Corporation Information
6.1.2 Alkermes Plc Description and Business Overview
6.1.3 Alkermes Plc Antidepressant Medication Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Alkermes Plc Antidepressant Medication Product Portfolio
6.1.5 Alkermes Plc Recent Developments/Updates
6.2 AbbVie Inc
6.2.1 AbbVie Inc Corporation Information
6.2.2 AbbVie Inc Description and Business Overview
6.2.3 AbbVie Inc Antidepressant Medication Sales, Revenue and Gross Margin (2017-2022)
6.2.4 AbbVie Inc Antidepressant Medication Product Portfolio
6.2.5 AbbVie Inc Recent Developments/Updates
6.3 Eli Lilly And Company
6.3.1 Eli Lilly And Company Corporation Information
6.3.2 Eli Lilly And Company Description and Business Overview
6.3.3 Eli Lilly And Company Antidepressant Medication Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Eli Lilly And Company Antidepressant Medication Product Portfolio
6.3.5 Eli Lilly And Company Recent Developments/Updates
6.4 GlaxoSmithKline, Inc.
6.4.1 GlaxoSmithKline, Inc. Corporation Information
6.4.2 GlaxoSmithKline, Inc. Description and Business Overview
6.4.3 GlaxoSmithKline, Inc. Antidepressant Medication Sales, Revenue and Gross Margin (2017-2022)
6.4.4 GlaxoSmithKline, Inc. Antidepressant Medication Product Portfolio
6.4.5 GlaxoSmithKline, Inc. Recent Developments/Updates
6.5 Merck KGAA
6.5.1 Merck KGAA Corporation Information
6.5.2 Merck KGAA Description and Business Overview
6.5.3 Merck KGAA Antidepressant Medication Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Merck KGAA Antidepressant Medication Product Portfolio
6.5.5 Merck KGAA Recent Developments/Updates
6.6 Pfizer Inc.
6.6.1 Pfizer Inc. Corporation Information
6.6.2 Pfizer Inc. Description and Business Overview
6.6.3 Pfizer Inc. Antidepressant Medication Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Pfizer Inc. Antidepressant Medication Product Portfolio
6.6.5 Pfizer Inc. Recent Developments/Updates
6.7 Teva Pharmaceutical Industries Ltd. (Actavis Generics)
6.6.1 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Antidepressant Medication Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Antidepressant Medication Product Portfolio
6.7.5 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Recent Developments/Updates
6.8 Takeda Pharmaceutical Limited Company.
6.8.1 Takeda Pharmaceutical Limited Company. Corporation Information
6.8.2 Takeda Pharmaceutical Limited Company. Description and Business Overview
6.8.3 Takeda Pharmaceutical Limited Company. Antidepressant Medication Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Takeda Pharmaceutical Limited Company. Antidepressant Medication Product Portfolio
6.8.5 Takeda Pharmaceutical Limited Company. Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Corporation Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Antidepressant Medication Sales, Revenue and Gross Margin (2017-2022)
6.9.4 AstraZeneca Antidepressant Medication Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
7 Antidepressant Medication Manufacturing Cost Analysis
7.1 Antidepressant Medication Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antidepressant Medication
7.4 Antidepressant Medication Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antidepressant Medication Distributors List
8.3 Antidepressant Medication Customers
9 Antidepressant Medication Market Dynamics
9.1 Antidepressant Medication Industry Trends
9.2 Antidepressant Medication Market Drivers
9.3 Antidepressant Medication Market Challenges
9.4 Antidepressant Medication Market Restraints
10 Global Market Forecast
10.1 Antidepressant Medication Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antidepressant Medication by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Antidepressant Medication by Type (2023-2028)
10.2 Antidepressant Medication Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antidepressant Medication by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Antidepressant Medication by Application (2023-2028)
10.3 Antidepressant Medication Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antidepressant Medication by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Antidepressant Medication by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Antidepressant Medication Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Antidepressant Medication Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Antidepressant Medication Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Antidepressant Medication Market Competitive Situation by Manufacturers in 2021
Table 5. Global Antidepressant Medication Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Antidepressant Medication Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Antidepressant Medication Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Antidepressant Medication Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Antidepressant Medication Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Antidepressant Medication Manufacturing Sites and Area Served
Table 11. Manufacturers Antidepressant Medication Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antidepressant Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidepressant Medication as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antidepressant Medication Sales by Region (2017-2022) & (K Units)
Table 16. Global Antidepressant Medication Sales Market Share by Region (2017-2022)
Table 17. Global Antidepressant Medication Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Antidepressant Medication Revenue Market Share by Region (2017-2022)
Table 19. North America Antidepressant Medication Sales by Country (2017-2022) & (K Units)
Table 20. North America Antidepressant Medication Sales Market Share by Country (2017-2022)
Table 21. North America Antidepressant Medication Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Antidepressant Medication Revenue Market Share by Country (2017-2022)
Table 23. Europe Antidepressant Medication Sales by Country (2017-2022) & (K Units)
Table 24. Europe Antidepressant Medication Sales Market Share by Country (2017-2022)
Table 25. Europe Antidepressant Medication Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Antidepressant Medication Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Antidepressant Medication Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Antidepressant Medication Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Antidepressant Medication Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Antidepressant Medication Revenue Market Share by Region (2017-2022)
Table 31. Latin America Antidepressant Medication Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Antidepressant Medication Sales Market Share by Country (2017-2022)
Table 33. Latin America Antidepressant Medication Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Antidepressant Medication Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Antidepressant Medication Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Antidepressant Medication Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Antidepressant Medication Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Antidepressant Medication Revenue Market Share by Country (2017-2022)
Table 39. Global Antidepressant Medication Sales by Type (2017-2022) & (K Units)
Table 40. Global Antidepressant Medication Sales Market Share by Type (2017-2022)
Table 41. Global Antidepressant Medication Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Antidepressant Medication Revenue Share by Type (2017-2022)
Table 43. Global Antidepressant Medication Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Antidepressant Medication Sales (K Units) by Application (2017-2022)
Table 45. Global Antidepressant Medication Sales Market Share by Application (2017-2022)
Table 46. Global Antidepressant Medication Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Antidepressant Medication Revenue Share by Application (2017-2022)
Table 48. Global Antidepressant Medication Price by Application (2017-2022) & (US$/Unit)
Table 49. Alkermes Plc Corporation Information
Table 50. Alkermes Plc Description and Business Overview
Table 51. Alkermes Plc Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Alkermes Plc Antidepressant Medication Product
Table 53. Alkermes Plc Recent Developments/Updates
Table 54. AbbVie Inc Corporation Information
Table 55. AbbVie Inc Description and Business Overview
Table 56. AbbVie Inc Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. AbbVie Inc Antidepressant Medication Product
Table 58. AbbVie Inc Recent Developments/Updates
Table 59. Eli Lilly And Company Corporation Information
Table 60. Eli Lilly And Company Description and Business Overview
Table 61. Eli Lilly And Company Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Eli Lilly And Company Antidepressant Medication Product
Table 63. Eli Lilly And Company Recent Developments/Updates
Table 64. GlaxoSmithKline, Inc. Corporation Information
Table 65. GlaxoSmithKline, Inc. Description and Business Overview
Table 66. GlaxoSmithKline, Inc. Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. GlaxoSmithKline, Inc. Antidepressant Medication Product
Table 68. GlaxoSmithKline, Inc. Recent Developments/Updates
Table 69. Merck KGAA Corporation Information
Table 70. Merck KGAA Description and Business Overview
Table 71. Merck KGAA Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Merck KGAA Antidepressant Medication Product
Table 73. Merck KGAA Recent Developments/Updates
Table 74. Pfizer Inc. Corporation Information
Table 75. Pfizer Inc. Description and Business Overview
Table 76. Pfizer Inc. Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Pfizer Inc. Antidepressant Medication Product
Table 78. Pfizer Inc. Recent Developments/Updates
Table 79. Teva Pharmaceutical Industries Ltd. (Actavis Generics) Corporation Information
Table 80. Teva Pharmaceutical Industries Ltd. (Actavis Generics) Description and Business Overview
Table 81. Teva Pharmaceutical Industries Ltd. (Actavis Generics) Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Teva Pharmaceutical Industries Ltd. (Actavis Generics) Antidepressant Medication Product
Table 83. Teva Pharmaceutical Industries Ltd. (Actavis Generics) Recent Developments/Updates
Table 84. Takeda Pharmaceutical Limited Company. Corporation Information
Table 85. Takeda Pharmaceutical Limited Company. Description and Business Overview
Table 86. Takeda Pharmaceutical Limited Company. Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Takeda Pharmaceutical Limited Company. Antidepressant Medication Product
Table 88. Takeda Pharmaceutical Limited Company. Recent Developments/Updates
Table 89. AstraZeneca Corporation Information
Table 90. AstraZeneca Description and Business Overview
Table 91. AstraZeneca Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. AstraZeneca Antidepressant Medication Product
Table 93. AstraZeneca Recent Developments/Updates
Table 94. Production Base and Market Concentration Rate of Raw Material
Table 95. Key Suppliers of Raw Materials
Table 96. Antidepressant Medication Distributors List
Table 97. Antidepressant Medication Customers List
Table 98. Antidepressant Medication Market Trends
Table 99. Antidepressant Medication Market Drivers
Table 100. Antidepressant Medication Market Challenges
Table 101. Antidepressant Medication Market Restraints
Table 102. Global Antidepressant Medication Sales Forecast by Type (2023-2028) & (K Units)
Table 103. Global Antidepressant Medication Sales Market Share Forecast by Type (2023-2028)
Table 104. Global Antidepressant Medication Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 105. Global Antidepressant Medication Revenue Market Share Forecast by Type (2023-2028)
Table 106. Global Antidepressant Medication Sales Forecast by Application (2023-2028) & (K Units)
Table 107. Global Antidepressant Medication Sales Market Share Forecast by Application (2023-2028)
Table 108. Global Antidepressant Medication Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 109. Global Antidepressant Medication Revenue Market Share Forecast by Application (2023-2028)
Table 110. Global Antidepressant Medication Sales Forecast by Region (2023-2028) & (K Units)
Table 111. Global Antidepressant Medication Sales Market Share Forecast by Region (2023-2028)
Table 112. Global Antidepressant Medication Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 113. Global Antidepressant Medication Revenue Market Share Forecast by Region (2023-2028)
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antidepressant Medication
Figure 2. Global Antidepressant Medication Market Share by Type in 2021 & 2028
Figure 3. Monoamine Oxidase Product Picture
Figure 4. Tricyclic Product Picture
Figure 5. New Drugs Product Picture
Figure 6. Global Antidepressant Medication Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Institute of Medicine
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Antidepressant Medication Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Antidepressant Medication Market Size (2017-2028) & (US$ Million)
Figure 13. Global Antidepressant Medication Sales (2017-2028) & (K Units)
Figure 14. Antidepressant Medication Sales Share by Manufacturers in 2021
Figure 15. Global Antidepressant Medication Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Antidepressant Medication Players: Market Share by Revenue in 2021
Figure 17. Antidepressant Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Antidepressant Medication Sales Market Share by Region (2017-2022)
Figure 19. Global Antidepressant Medication Sales Market Share by Region in 2021
Figure 20. Global Antidepressant Medication Revenue Market Share by Region (2017-2022)
Figure 21. Global Antidepressant Medication Revenue Market Share by Region in 2021
Figure 22. United States Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Colombia Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Antidepressant Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Antidepressant Medication by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Antidepressant Medication
Figure 47. Manufacturing Process Analysis of Antidepressant Medication
Figure 48. Antidepressant Medication Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed